GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Benevolent AI (GREY:BAIVF) » Definitions » Beginning Cash Position

Benevolent AI (Benevolent AI) Beginning Cash Position : $77.43 Mil (As of Dec. 2023)


View and export this data going back to 2023. Start your Free Trial

What is Benevolent AI Beginning Cash Position?

Benevolent AI's Beginning Cash Position for the quarter that ended in Dec. 2023 was $77.43 Mil.

Benevolent AI's quarterly Beginning Cash Position declined from Dec. 2022 ($201.39 Mil) to Jun. 2023 ($111.67 Mil) and declined from Jun. 2023 ($111.67 Mil) to Dec. 2023 ($77.43 Mil).

Benevolent AI's annual Beginning Cash Position declined from Dec. 2021 ($113.53 Mil) to Dec. 2022 ($49.40 Mil) but then increased from Dec. 2022 ($49.40 Mil) to Dec. 2023 ($111.95 Mil).


Benevolent AI Beginning Cash Position Historical Data

The historical data trend for Benevolent AI's Beginning Cash Position can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Benevolent AI Beginning Cash Position Chart

Benevolent AI Annual Data
Trend Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Beginning Cash Position
Get a 7-Day Free Trial 42.60 115.92 113.53 49.40 111.95

Benevolent AI Quarterly Data
Dec18 Dec19 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23
Beginning Cash Position Get a 7-Day Free Trial Premium Member Only - 49.94 201.39 111.67 77.43

Benevolent AI Beginning Cash Position Calculation

Beginning Cash Position is the cash and equivalents balance at the beginning of the accounting period, as indicated on the Cash Flow statement.


Benevolent AI Beginning Cash Position Related Terms

Thank you for viewing the detailed overview of Benevolent AI's Beginning Cash Position provided by GuruFocus.com. Please click on the following links to see related term pages.


Benevolent AI (Benevolent AI) Business Description

Comparable Companies
Traded in Other Exchanges
Address
4-8 Maple Street, London, GBR, W1T 5HD
Benevolent AI is a clinical-stage AI-enabled drug discovery company. It delivers novel drug candidates with a higher probability of clinical success than those developed using traditional methods. The Benevolent Platform powers a growing in-house pipeline of over 20 drug programmes, spanning from target discovery to clinical studies, and it maintains commercial collaborations with pharmaceutical companies.